{"chunk_id": "medquad__chunk_31306", "source": "medquad", "text": "ng factor. Antibodies can destroy the clotting factor before it has a chance to work. This is a very serious problem. It prevents the main treatment for hemophilia (replacement therapy) from working.\n                \nThese antibodies, also called inhibitors, develop in about 2030 percent of people who have severe hemophilia A. Inhibitors develop in 25 percent of people who have hemophilia B.\n                \nWhen antibodies develop, doctors may use larger doses of clotting factor or try differen"}